Novel compounds having inhibitory activity against sodium-dependant glucose transporter
申请人:Mitsubishi Tanabe Pharma Corporation
公开号:EP2896397B2
公开(公告)日:2020-10-07
Tetracyline Compounds
申请人:Tetraphase Pharmaceuticals, Inc.
公开号:US20170305852A1
公开(公告)日:2017-10-26
The present invention is directed to a compound represented by Structural Formula (I):
or a pharmaceutically acceptable salt thereof. The variables for Structural Formula (I) are defined herein. Also described is a pharmaceutical composition comprising the compound of Structural Formula (I), or a pharmaceutically acceptable salt thereof, and its therapeutic use.